KalVista Pharmaceuticals, Inc. (KALV) Deferred Tax Assets, Net of Valuation Allowance USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
KalVista Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from 2014 to 2023.
  • KalVista Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending April 30, 2023 was $1.76 M, a 11.7% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $1.76 M +$185 K +11.7% Apr 30, 2023 10-K 2023-07-10
Q1 2022 $1.58 M +$399 K +33.9% Apr 30, 2022 10-K 2023-07-10
Q1 2021 $1.18 M Apr 30, 2021 10-K 2022-07-07
Q4 2015 $63 K -$1.12 M -94.7% Dec 31, 2015 10-K 2016-03-30
Q4 2014 $1.18 M Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.